CONGENITAL HYPOTHYROIDISM - THE IMPORTANCE OF SCREENING AND TREATMENT OPTIMIZATION IN CHILDREN
Abstract
Introduction and objective: Congenital hypothyroidism (CH) is an endocrine disorder that can lead to physical and cognitive impairment if not properly treated. The aim of this review is to discuss the importance of screening and treatment optimization in childhood, within the context of the healthcare system in Poland, with reference to European standards. The article also discusses the most important issues related to the topic of CH.
Review methods: This article is based on a literature review from 2009 to 2025, with more focus put on papers published after 2017, analyzing national and international diagnostic, therapeutic guidelines, and long-term treatment outcomes. It also analyzes the challenges of differentiating permanent and transient forms and strategies for therapy monitoring.
State of knowledge: Early diagnosis and treatment of CH (before 14th day of life) are crucial in preventing neurodevelopmental delays. Treatment involves lifelong thyroid hormone replacement therapy, but in cases of transient hypothyroidism, the withdrawal of the therapy at 2–3 years of age can be taken into consideration. Challenges in the topic of CH include diagnosing milder forms and personalizing treatment.
Summary: Despite significant progress in CH diagnosis and treatment over the years, precise diagnosing and adjusting therapy to individual patient needs still remain a challenge. Future research should focus on developing better diagnostic tools, adjusting treatment to personal needs, and monitoring long-term neurodevelopmental outcomes among the pediatric population.
References
LaFranchi SH. Approach to the diagnosis and treatment of neonatal hypothyroidism. J Clin Endocrinol Metab. 2011 Oct;96(10):2959-67. https://doi.org/10.1210/jc.2011-1175.
Hubalewska-Dydejczyk A, Trofimiuk-Müldner M, Ruchala M i wsp. Thyroid diseases in pregnancy: guidelines of the Polish Society of Endocrinology [Choroby tarczycy w ciąży: zalecenia postępowania Polskiego Towarzystwa Endokrynologicznego]. Endokrynol Pol. 2021;72(5):425-488. https://doi.org/10.5603/EP.a2021.0089.
van Trotsenburg P, Stoupa A, Léger J et al. Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid. 2021 Mar;31(3):387-419. https://doi.org/10.1089/thy.2020.0333.
Stoupa A, Kariyawasam D, Polak M et al. Genetics of congenital hypothyroidism: Modern concepts. Pediatr Investig. 2022 May 14;6(2):123-134. https://doi.org/10.1002/ped4.12324.
Peters C, van Trotsenburg ASP, Schoenmakers N. DIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives. Eur J Endocrinol. 2018 Dec 1;179(6):R297-R317. https://doi.org/10.1530/EJE-18-0383.
Arrigoni M, Zwaveling-Soonawala N, LaFranchi SH et al. Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start. Eur Thyroid J. 2025 Jan 31;14(1):e240327. https://doi.org/10.1530/ETJ-24-0327.
Dimitropoulos A, Molinari L, Etter K et al. Children with congenital hypothyroidism: long-term intellectual outcome after early high-dose treatment. Pediatr Res. 2009 Feb;65(2):242-8. https://doi.org/10.1203/PDR.0b013e31818d2030.
Polska Agencja Oceny Technologii Medycznych i Taryfikacji. Profilaktyka chorób tarczycy – aktualizacja 2022. Raport nr: OT.434.5.2022. https://www.aotm.gov.pl/wp-content/uploads/2024/05/Raport-AOTMiT.pdf (access 10.05.2025)
Léger J, Olivieri A, Donaldson M et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab. 2014 Feb;99(2):363-84. https://doi.org/10.1210/jc.2013-1891.
Grob F, Lain S, Olivieri A. Newborn screening for primary congenital hypothyroidism: past, present and future. Eur Thyroid J. 2025 Mar 3;14(2):e240358. https://doi.org/10.1530/ETJ-24-0358.
Nazari J, Jafari K, Chegini M et al. Physical and mental growth and development in children with congenital hypothyroidism: a case-control study. Orphanet J Rare Dis. 2021 Sep 23;16(1):393. https://doi.org/10.1186/s13023-021-02017-7. Erratum in: Orphanet J Rare Dis. 2021 Dec 7;16(1):506. https://doi.org/10.1186/s13023-021-02131-6.
Rose SR, Wassner AJ, Wintergerst KA et al. Congenital Hypothyroidism: Screening and Management. Pediatrics. 2023 Jan 1;151(1):e2022060419. https://doi.org/10.1542/peds.2022-060419.
Views:
26
Downloads:
16
Copyright (c) 2025 Radosław Kuźma, Adrianna Samoraj, Jakub Zajączkowski, Karolina Marrodán-Wojtczak, Jan Wilk, Kacper Stępniak, Jakub Jarmołowicz, Aleksandra Kujawa, Karolina Krochmal, Paulina Krzeszowska

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.